Skip to main content

Affy and IBM to Collaborate on Integrating Genomic, Patient Data

NEW YORK, GenomeWeb News (March 30) - IBM and Affymetrix will collaborate to integrate genomic research data and patient information, the companies said today.


Affymetrix and IBM plan to combine open standards technologies, including Affymetrix's GeneChip technology and IBM's services in regulatory compliance, business integration, and systems integration, to create a system that will allow researchers to cross-reference genomic data with patient data.


In their collaboration, IBM and Affymetrix plan to work with research organizations and institutes, pharmaceutical companies, and other organizations.


The H. Lee Moffitt Cancer Center and Research Institute at the University of South Florida will collaborate with the two companies to design clinical trials that take into account genetic research.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.